Atea Pharmaceuticals Inc
(AVIR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,603 | -13,981 | -3,988 | -14,034 | -9,064 |
| Depreciation Amortization | 13 | 8 | 4 | 17 | 17 |
| Accounts payable and accrued liabilities | 3,689 | 2,643 | -150 | N/A | N/A |
| Other Working Capital | 5,167 | 1,269 | -713 | 564 | 725 |
| Other Operating Activity | 947 | -2,245 | 339 | 624 | 414 |
| Operating Cash Flow | $-21,787 | $-12,306 | $-4,508 | $-12,829 | $-7,908 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -6 | N/A | -2 | -12 |
| Investing Cash Flow | $-21 | $-6 | $N/A | $-2 | $-12 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27 | 27 | -6 | N/A | N/A |
| Other Financing Activity | 105,503 | 106,416 | 0 | 0 | 27,483 |
| Financing Cash Flow | $105,530 | $106,443 | $-6 | $0 | $27,483 |
| Beginning Cash Position | 21,768 | 21,768 | 21,768 | 34,599 | 15,036 |
| End Cash Position | 105,490 | 115,899 | 17,254 | 21,768 | 34,599 |
| Net Cash Flow | $83,722 | $94,131 | $-4,514 | $-12,831 | $19,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,787 | -12,306 | -4,508 | -12,829 | -7,908 |
| Capital Expenditure | -21 | -6 | N/A | N/A | N/A |
| Free Cash Flow | -21,808 | -12,312 | -4,508 | -12,829 | -7,908 |